Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026)
Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 17.02 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.32 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -37.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -1.52 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.17 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 217,225.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 493.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -7.36 Mn |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | 34.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.59 Mn |
| Dec 31, 2025 | 33.66 Mn |
| Sep 30, 2025 | 41.63 Mn |
| Jun 30, 2025 | 46.65 Mn |
| Mar 31, 2025 | 54.65 Mn |
| Dec 31, 2024 | 77.19 Mn |
| Sep 30, 2024 | 37.76 Mn |
| Jun 30, 2024 | 31.83 Mn |
| Mar 31, 2024 | 31.41 Mn |
| Dec 31, 2023 | 30.46 Mn |
| Sep 30, 2023 | 29.20 Mn |
| Jun 30, 2023 | 28.29 Mn |
| Mar 31, 2023 | 22.87 Mn |
| Dec 31, 2022 | 19.84 Mn |
| Sep 30, 2022 | 19.49 Mn |
| Jun 30, 2022 | 21.20 Mn |
| Mar 31, 2022 | 21.07 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Sep 30, 2021 | 15.69 Mn |
| Jun 30, 2021 | 13.85 Mn |